听力效用测量工具(HUM)在人工耳蜗候选者与使用者中的验证
前瞻性队列研究纳入1315例人工耳蜗候选者,验证HUM与CIQOL-全球(r=0.69)及SSQ-总体(r=0.70)强相关,重测信度ICC为0.90。HUM在单侧聋候选者中为0.76,高于传统及非对称性听力损失者的0.58(P<.001)。结论认为HUM是可靠、有效且反应性良好的听力相关健康测量工具。
要点
- HUM与CIQOL-全球(r=0.69)和SSQ-总体(r=0.70)强相关,支持结构效度。
- HUM耳鸣域与THI呈负相关(-0.75),符合预期。
- 重测信度ICC为0.90(95%CI 0.83-0.94),单侧聋候选者HUM为0.76,高于传统及非对称性听力损失者的0.58(P<.001)。
核心结论
- HUM是成人重度听力损失中可靠、有效且反应性良好的听力相关健康测量工具。
- HUM是基于偏好的效用工具,可用于成本效果评估,优于现有HUI-3,并补充现有非效用工具。
研究设计与样本
- 前瞻性队列研究,在三级学术中心开展。
- 2020年6月25日至2024年3月17日纳入人工耳蜗候选者,共1315例参与者。
- 参与者在人工耳蜗评估时及激活后12个月完成HUM及其他评估,包括HUI-3、SSQ-49、CIQOL-35和THI。
- 听力状态稳定的亚组间隔6个月完成两次HUM以评估重测信度。
主要发现
- HUM与CIQOL-全球强相关(r=0.69;95%CI 0.66-0.72),与SSQ-总体强相关(r=0.70;95%CI 0.67-0.73)。
- HUM耳鸣域与THI呈负相关(-0.75;95%CI -0.77至-0.73),符合预期。
- 重测信度优秀(ICC 0.90;95%CI 0.83-0.94)。
- 单侧聋候选者HUM听力效用为0.76,高于传统及非对称性听力损失者的0.58(P<.001)。
- 单侧聋接受者HUM中位数从0.70改善至0.78(P=.002),传统接受者从0.57改善至0.75(P<.001)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To validate the Hearing Utility Measure (HUM), a tool designed to quantify hearing loss impact on health and quality of life for use in economic evaluation. STUDY DESIGN: Prospective cohort. SETTING: Tertiary academic center. METHODS: Cochlear implant (CI) candidates were enrolled between June 25, 2020, and March 17, 2024. Participants completed HUM alongside other assessments, including Health Utilities Index, Mark-3 (HUI-3), Speech, Spatial and Qualities of Hearing Scale (SSQ-49), Cochlear Implant Quality of Life Profile (CIQOL-35), and Tinnitus Handicap Inventory (THI) at the time of CI evaluation and 12 months post-activation. A subgroup with stable hearing status completed HUM twice, 6 months apart, to assess test-retest reliability. RESULTS: Among 1315 participants, HUM showed strong correlations with CIQOL-global (r = 0.69; 95% CI: 0.66-0.72) and SSQ-overall (r = 0.70; 95% CI: 0.67-0.73), supporting construct validity. HUM Tinnitus domain correlated negatively with THI (-0.75; -0.77, -0.73), as expected. Test-retest reliability was excellent (Intraclass Correlation Coefficient [ICC] 0.90, 95% CI: 0.83-0.94). HUM hearing utility was higher for candidates with single-sided deafness (SSD) (0.76) than with traditional and asymmetric hearing loss (0.58, P < .001). Median HUM improved from 0.70 to 0.78 for SSD recipients (P = .002) and 0.57 to 0.75 for traditional recipients (P < .001). CONCLUSION: HUM is a reliable, valid, and responsive measure of hearing-related health in adults with advanced hearing loss. Unlike traditional instruments such as SSQ and CIQOL, which capture patient-reported outcomes but are not designed for economic analysis, HUM is a preference-based utility instrument that enables cost-effectiveness evaluation. It outperforms the available HUI-3 by better reflecting hearing loss impact and complements existing nonutility instruments used in clinical and health policy decision-making.
引用
- Dixon PR, Shah AH, McRackan TR, et al. Validation of the Hearing Utility Measure (HUM) in Cochlear Implant Candidates and Users. Otolaryngol Head Neck Surg. 2025. PMID: 41084342. doi:10.1002/ohn.70033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。